Firstly, we demonstrated that circulating levels of SEMA3A, SEMA3C, SEMA5A, SEMA6B and SEMA6D are detectable and elevated in the serum of patients with CHC. This evidence concerns the gene SEMA3A and cryohydrocytosis.